● Recruiting

Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)

Condition: Prostate Adenocarcinoma · Localized Prostate Carcinoma · Sponsor: Shanghai Changzheng Hospital

PhaseNA

Planned participants480

Who can joinMale, 18 Years to 75 Years

Healthy volunteersNo

About this study

This study is a two-arm, multicenter, randomized controlled clinical trial on whether single-port extraperitoneal VIP RARP is non-inferior to multi-port transperitoneal RARP in terms of functional recovery rate and other key metrics.

This description comes directly from the study's public registry record.

Talk to the study team

Shancheng Ren, MD/PhD · 021-81886999 · renshancheng@gmail.com

Yi fan Chang · 13661652533 · 13661652533@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Changzheng hospital

Shanghai, Shanghai Municipality, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06238713